Campbell & Co Investment Adviser’s The Marzetti Company MZTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,356
Closed -$2.03M 1251
2025
Q4
$2.03M Buy
12,356
+10,886
+741% +$1.82M 0.1% 327
2025
Q3
$254K Buy
+1,470
New +$264K 0.02% 960
2025
Q2
Sell
-14,040
Closed -$2.46M 1304
2025
Q1
$2.46M Buy
+14,040
New +$2.53M 0.19% 145
2024
Q3
Sell
-3,167
Closed -$598K 1225
2024
Q2
$598K Buy
+3,167
New +$605K 0.05% 584
2023
Q4
Sell
-9,692
Closed -$1.6M 1222
2023
Q3
$1.6M Buy
+9,692
New +$1.74M 0.19% 137
2022
Q1
Sell
-2,750
Closed -$455K 802
2021
Q4
$455K Sell
2,750
-10,400
-79% -$1.7M 0.16% 228
2021
Q3
$2.22M Buy
+13,150
New +$2.43M 0.72% 6
2021
Q2
Sell
-1,876
Closed -$329K 627
2021
Q1
$329K Buy
+1,876
New +$336K 0.2% 202
2018
Q1
Sell
-1,707
Closed -$221K 445
2017
Q4
$221K Buy
+1,707
New +$215K 0.16% 291
2017
Q2
Sell
-2,797
Closed -$360K 348
2017
Q1
$360K Buy
+2,797
New +$375K 0.93% 34

Other funds holding MZTI

Campbell & Co Investment Adviser's MZTI Position: Q1 2026 in Review

Campbell & Co Investment Adviser sold out of The Marzetti Company (MZTI) in Q1 2026, closing a stake of 12,356 shares — an estimated $2.03M sold.

Campbell & Co Investment Adviser first reported a position in MZTI in Q1 2017 and held it in 10 quarters. The position peaked at $2.46M in Q1 2025. 361 funds tracked by Wall St. Rank hold MZTI as of Q1 2026.

  • Campbell & Co Investment Adviser reported no remaining The Marzetti Company position as of Q1 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 12,356 The Marzetti Company shares in Q1 2026, an estimated $2.03M.
  • Campbell & Co Investment Adviser first reported a position in The Marzetti Company in Q1 2017 and held it in 10 quarters.
  • Campbell & Co Investment Adviser's The Marzetti Company position peaked at $2.46M in Q1 2025.
  • 361 funds tracked by Wall St. Rank held The Marzetti Company as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.